|
|
| Click here for links to all Expanded Tables of Contents |
|
EXPANDED TABLE OF CONTENTS VOLUME 6, NUMBER 10 OCTOBER 2003 |
| TREATMENT HIGHLIGHTS |
| HABIT REVERSAL THERAPY FOR TOURETTE’S DISORDER |
| Habit reversal therapy may be effective in the treatment of Tourette’s disorder. |
| COMMUNITY REINFORCEMENT APPROACH IN THE TREATMENT OF COCAINE DEPENDENCE |
| Community reinforcement approach (CRA) therapy is found to have beneficial effects in treating patients with cocaine dependence. |
| OF NOTE |
| Impact of Exercise on Weight Loss in Sedentary Women |
| ETCETERA |
| Prevalence of Different Forms of Violence in the Lives of Children and Youth |
| PSYCHOPHARMACOLOGY NOTE |
| ADJUNCT MODAFINIL IN THE TREATMENT OF SLEEPINESS AND FATIGUE IN PATIENTS WITH DEPRESSION |
| Preliminary evidence suggests that modafinil (Provigil) improves daytime sleepiness and fatigue when used as a short-term adjunct treatment for patients with major depression who are partially responsive to antidepressants. |
| FDA NEWS AND REVIEW |
| Approval (new drug) of Pexeva (paroxetine mesylate). Indications: treatment of major depressive disorder, obsessive-compulsive disorder, panic disorder.
Approval (new drug) of Namenda (memantine hydrochloride). Indication: treatment of moderate to severe dementia of the Alzheimer’s type Product Safety Information: The labeling for Effexor and Effexor XR (venlafaxine hydrochloride) has been changed to include a warning concerning its use in pediatric patients. Product Safety Information: The sale and distribution of ORLAAM (levomethadyl hydrochloride acetate) is being discontinued. |
| ASSESSMENT |
| Anorexia Nervosa |
| RESOURCES |
| Each issue presents descriptions of clinical resources (eg, professional materials, patient handouts) and information on how to receive those materials. |